Andrew Gengos
CIK 1563623 · Chief Financial Officer · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$60.5K
Companies
7
Total Filings
28
Lifetime Open-Market Net
$389.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TTRX | Director | 10,000 | $6.04 | $60.5K | $0 | 2 | 2026-06-08 |
| Terns Pharmaceuticals, Inc. (TERN) Delisted | Chief Financial Officer | 0 | $52.95 | $0 | $96.4K | 5 | 2026-05-05 |
| LeonaBio, Inc. (ATHA) Delisted | CFO and Chief Business Officer | 97,532 | $6.92 | $674.9K | $235.3K | 7 | 2024-09-05 |
| Cyteir Therapeutics, Inc. (CYT) Delisted | Chief Business Officer | — | $3.02 | — | $0 | 1 | 2022-02-24 |
| SYBX | Chief Operating Officer | — | $0.69 | — | $0 | 2 | 2018-03-15 |
| ImmunoCellular Therapeutics, Ltd. (IMUC.WS) Delisted | Director | 6,424 | — | — | $0 | 1 | 2017-02-13 |
| ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | President and CEO | 388,333 | — | — | $57.5K | 10 | 2016-03-15 |
Recent Filings · Page 2 of 3
28 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-01-08 | LeonaBio, Inc. (ATHA) Delisted | Mixed | +3,792 | -$3.5K | EDGAR |
| 2023-06-09 | LeonaBio, Inc. (ATHA) Delisted | Buy (P) | +15,000 | $51.4K | EDGAR |
| 2023-06-06 | LeonaBio, Inc. (ATHA) Delisted | Buy (P) | +65,012 | $191.6K | EDGAR |
| 2023-05-22 | LeonaBio, Inc. (ATHA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-24 | Cyteir Therapeutics, Inc. (CYT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-03-15 | SYBX | Grant (A) | — | $0 | EDGAR |
| 2017-12-22 | SYBX | Grant (A) | — | $0 | EDGAR |
| 2017-02-13 | ImmunoCellular Therapeutics, Ltd. (IMUC.WS) Delisted | Tax (F) | −3,284 | -$6.7K | EDGAR |
| 2016-03-15 | ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Grant (A) | +150,000 | $0 | EDGAR |
| 2015-12-02 | ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Buy (P) | +10,000 | $4.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.